NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

MygeA.00914.a: Glyceraldehyde-3-phosphate dehydrogenase (MG_301)

Target Characteristics

from organism: Mycoplasma genitalium ATCC 33530 / G-37 / NCTC 10195
most recent status: purified
center reference id: MygeA.00914.a
is community request: True
associated disease:
NIH risk group: unclassified
is select agent: False
NIH priority
pathogens category:
C

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Clones*

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
MygeA.00914.a.B1.GE42342 Full length(MygeA.00914.a) 1 337 GE42342
MygeA.00914.a.B2.GE43067 XtalPred domain 6 337 GE43067
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis. Get sequence information using the button in the "info" column.

Proteins

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
MygeA.00914.a.A11.PW38712 Full length(MygeA.00914.a) 1 337

Molecular models

Method Results
comparative modelling Robetta_81180

External Resources

Resource Reference ID
PATRIC ID: fig|243273.25.peg.352
UniProt: P47543

Enzyme & Pathway Information

Pathway Pathway ID EC Number
homolactic fermentation ANAEROFRUCAT-PWY 1.2.1.12
glycolysis III (from glucose) ANAGLYCOLYSIS-PWY 1.2.1.12
gluconeogenesis I GLUCONEO-PWY 1.2.1.12
glycolysis I (from glucose 6-phosphate) GLYCOLYSIS 1.2.1.12
superpathway of glycolysis and the Entner-Doudoroff pathway GLYCOLYSIS-E-D 1.2.1.12
superpathway of glycolysis, pyruvate dehydrogenase, TCA, and glyoxylate bypass GLYCOLYSIS-TCA-GLYOX-BYPASS 1.2.1.12
superpathway of hexitol degradation (bacteria) HEXITOLDEGSUPER-PWY 1.2.1.12
heterolactic fermentation P122-PWY 1.2.1.12
Bifidobacterium shunt P124-PWY 1.2.1.12
formaldehyde assimilation III (dihydroxyacetone cycle) P185-PWY 1.2.1.12
superpathway of N-acetylneuraminate degradation P441-PWY 1.2.1.12
hexitol fermentation to lactate, formate, ethanol and acetate P461-PWY 1.2.1.12
glycolysis IV (plant cytosol) PWY-1042 1.2.1.12
superpathway of cytosolic glycolysis (plants), pyruvate dehydrogenase and TCA cycle PWY-5464 1.2.1.12
glycolysis II (from fructose 6-phosphate) PWY-5484 1.2.1.12
gluconeogenesis III PWY66-399 1.2.1.12
glycolysis VI (metazoan) PWY66-400 1.2.1.12
superpathway of glucose and xylose degradation PWY-6901 1.2.1.12
glycerol degradation to butanol PWY-7003 1.2.1.12
superpathway of anaerobic sucrose degradation PWY-7345 1.2.1.12
sucrose biosynthesis I (from photosynthesis) SUCSYN-PWY 1.2.1.12

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MAAKNRTIKV AINGFGRIGR LVFRSLLSKA NVEVVAINDL TQPEVLAHLL KYDSAHGELK RKITVKQNIL QIDRKKVYVF SEKDPQNLPW DEHDIDVVIE STGRFVSEEG ASLHLKAGAK RVIISAPAKE KTIRTVVYNV NHKTISSDDK IISAASCTTN CLAPLVHVLE KNFGIVYGTM LTVHAYTADQ RLQDAPHNDL RRARAAAVNI VPTTTGAAKA IGLVVPEANG KLNGMSLRVP VLTGSIVELS VVLEKSPSVE QVNQAMKRFA SASFKYCEDP IVSSDVVSSE YGSIFDSKLT NIVEVDGMKL YKVYAWYDNE SSYVHQLVRV VSYCAKL

NT Sequence
ATGGCAGCAA AGAATAGAAC CATTAAGGTT GCAATCAATG GTTTTGGAAG AATTGGAAGA CTTGTTTTTC GTTCTCTTCT CAGTAAGGCA AATGTTGAAG TTGTAGCAAT TAATGATTTG ACCCAACCTG AAGTTTTAGC GCACCTGTTG AAATATGATT CAGCTCATGG TGAATTGAAA AGAAAGATTA CTGTTAAACA AAACATCTTG CAAATTGATA GAAAAAAGGT TTATGTTTTT AGTGAAAAAG ATCCCCAAAA TTTACCTTGG GATGAACATG ATATTGATGT AGTAATTGAA TCAACTGGTA GGTTTGTAAG TGAAGAGGGT GCTTCTCTCC ATTTAAAAGC AGGTGCTAAA AGAGTAATTA TTTCCGCACC CGCTAAAGAA AAAACTATCA GGACAGTTGT TTACAATGTT AATCACAAAA CCATTAGTAG CGATGATAAG ATCATCTCAG CAGCTAGCTG TACTACTAAC TGTTTAGCAC CATTAGTTCA TGTACTTGAA AAGAACTTTG GGATTGTTTA TGGAACGATG CTAACAGTTC ATGCATATAC TGCAGATCAA CGCTTACAAG ATGCTCCTCA TAATGACTTA CGTCGTGCTC GTGCTGCAGC TGTTAACATT GTGCCAACAA CAACAGGAGC AGCTAAAGCA ATTGGGCTTG TTGTTCCAGA AGCAAATGGC AAACTTAATG GGATGTCACT CCGTGTTCCA GTGTTAACTG GTTCTATTGT AGAGTTAAGT GTTGTACTTG AAAAAAGTCC ATCTGTTGAA CAAGTAAATC AAGCCATGAA GCGATTTGCT TCCGCTTCTT TTAAATATTG TGAAGATCCT ATTGTATCTA GCGATGTGGT AAGTTCTGAA TATGGTTCAA TTTTCGATTC TAAACTAACC AATATTGTTG AAGTTGATGG CATGAAACTT TATAAGGTGT ATGCATGGTA TGATAATGAA TCTTCCTATG TACACCAACT AGTGAGAGTA GTTAGCTATT GTGCTAAGCT C

© 2020 Seattle Children's Research Institute. All rights reserved.